新型亲环蛋白抑制剂JAK-103对腺嘌呤诱导的小鼠慢性肾损伤的保护作用OA
Protective Effects of the Novel Cyclophilin Inhibitor JAK-103 on Adenine-Induced Chronic Kidney Injury in Mice
目的 探讨新型亲环蛋白抑制剂JAK-103对腺嘌呤诱导的小鼠慢性肾损伤模型的作用,并初步探索其作用机制.方法 60只C57BL/6J小鼠随机分为空白对照组(Control组,n=10),模型组(n=50).模型组连续7 d灌胃给予腺嘌呤(90 mg·kg-1·d-1)以诱导慢性肾损伤模型.然后将模型组50只动物拆分为模型对照组(Model组)、达格列净组以及JAK-103低、中、高剂量组,每组10只,进行给药治疗,并于造模后第9、11、13和21天维持灌胃给予腺嘌呤(90 mg·kg-1·d-1).给药21 d后,收集尿液测定蛋白排泄量;采用CO2吸入法处死动物;采血检测血清尿素氮和肌酐含量;取双侧肾脏称重计算脏器指数;采用免疫组化方法分析TNF-α、IL-34、α-SMA和collagen I的表达水平,以及HE染色和Masson染色进行病理组织学检查;ELISA法检测IL-6、TGF-β、NF-κB和Caspase-3水平,同时测定肾组织氧化应激指标(GSH、SOD和MDA).结果 JAK-103表现出明显的肾脏保护作用,20、60和180 mg/kg的JAK-103能显著改善模型动物肾脏功能,中、高剂量组小鼠血清肌酐(CRE)水平较模型组显著降低(P<0.05);能一定程度降低肾脏指数,中、高剂量组能显著降低HE和Masson染色评分(P<0.05),减少肾间质纤维化面积;显著下调炎症和纤维化相关因子表达,同时改善肾组织氧化应激状态.结论 JAK-103对腺嘌呤诱导的小鼠慢性肾损伤具有保护作用,该作用与其抑制肾脏炎症、减轻肾间质纤维化相关,可有效改善肾功能并缓解肾组织病理损伤,延缓慢性肾损伤病理进程.
Objective To investigate the effects of JAK-103,a novel cyclophilin inhibitor,on the adenine-induced mouse model of chronic kidney injury and preliminarily explore its underlying mechanism.Methods Sixty C57BL/6J mice were randomly divided into a blank control group(Control group,n=10)and a model group(n=50).The model group was intragastrically adminis-tered adenine(90 mg·kg-1·d-1)for 7 consecutive days to induce a chronic kidney injury model.Subsequently,the 50 mice in the model group were further divided into a model control group(Model group),a dapagliflozin group,and three dose groups of JAK-103(low,medium,and high doses)with 10 mice per group for drug treatment.Meanwhile,maintenance doses of adenine(90 mg·kg-1·d-1)were intragastrically administered on days 9,11,13,and 21 after modeling.After 21 days of administration,urine samples were collected to measure protein excretion;mice were euthanized by CO₂ inhalation;blood samples were harvested to detect serum levels of urea nitrogen and creatinine;bilateral kidneys were excised and weighed to calculate the organ index;the expression levels of TNF-α,IL-34,α-smooth muscle actin(α-SMA)and Collagen I were analyzed by immunohistochemistry(IHC),and histopathological examina-tion was performed via HE and Masson's trichrome staining.The levels of IL-6,TGF-β,NF-κB and Caspase-3 were detected by ELISA,and the oxidative stress indexes(GSH,SOD,and MDA)in renal tissue were simultaneously determined.Results JAK-103 exhibited a significant renoprotective effect.Treatment with JAK-103 at 20,60 and 180 mg/kg significantly improved renal function in model mice;serum CRE levels in the medium and high-dose JAK-103 groups were markedly lower than those in the model group(P<0.05).JAK-103 also reduced the kidney index to a certain extent,and the medium-and high-dose groups significantly decreased the HE and Masson staining scores(P<0.05)and reduced the area of renal interstitial fibrosis.It significantly down-regulated the expres-sion of inflammation and fibrosis-related factors,and improved the oxidative stress status of renal tissue.Conclusion JAK-103 exerts a protective effect against adenine-induced chronic kidney injury in mice.This effect is associated with the inhibition of renal inflamma-tion and the alleviation of renal interstitial fibrosis.It can effectively improve renal function,mitigate renal histopathological damage,and delay the pathological progression of chronic kidney injury.
陈成;张文静;侯久文;徐铭泽;杜建军;梅其炳;曾静
西南医科大学 药学院(泸州 646000)||泸州新药评价研究中心(泸州 646000)西南医科大学 药学院(泸州 646000)||泸州新药评价研究中心(泸州 646000)西南医科大学 药学院(泸州 646000)||泸州新药评价研究中心(泸州 646000)泸州新药评价研究中心(泸州 646000)西南医科大学 药学院(泸州 646000)||泸州新药评价研究中心(泸州 646000)西南医科大学 药学院(泸州 646000)||泸州新药评价研究中心(泸州 646000)西南医科大学 药学院(泸州 646000)
医药卫生
亲环蛋白慢性肾病肿瘤坏死因子-α白细胞介素-34
CyclophilinChronic kidney diseaseTumor necrosis factor-αInterleukin-34
《西南医科大学学报》 2026 (5)
606-615,10
泸州新药评价研究中心合作项目(PD20240720)
评论